299 related articles for article (PubMed ID: 16207960)
1. Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.
Arpin C; Dubois V; Maugein J; Jullin J; Dutilh B; Brochet JP; Larribet G; Fischer I; Quentin C
J Clin Microbiol; 2005 Oct; 43(10):5048-54. PubMed ID: 16207960
[TBL] [Abstract][Full Text] [Related]
2. Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.
Arpin C; Quentin C; Grobost F; Cambau E; Robert J; Dubois V; Coulange L; André C;
J Antimicrob Chemother; 2009 Jun; 63(6):1205-14. PubMed ID: 19329798
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS
Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
[TBL] [Abstract][Full Text] [Related]
5. Extended-spectrum beta-lactamase-producing organisms.
Falagas ME; Karageorgopoulos DE
J Hosp Infect; 2009 Dec; 73(4):345-54. PubMed ID: 19596491
[TBL] [Abstract][Full Text] [Related]
6. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
Rodríguez-Baño J; Alcalá J; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
J Antimicrob Chemother; 2009 Apr; 63(4):781-4. PubMed ID: 19223299
[TBL] [Abstract][Full Text] [Related]
7. [Recent evolution and characterization of extended-spectrum beta-lactamase producing enterobacteria in the CHU of Nice (2005-2007)].
Giraud-Morin C; Fosse T
Pathol Biol (Paris); 2008; 56(7-8):417-23. PubMed ID: 18848404
[TBL] [Abstract][Full Text] [Related]
8. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal.
Machado E; Coque TM; Cantón R; Novais A; Sousa JC; Baquero F; Peixe L;
J Antimicrob Chemother; 2007 Dec; 60(6):1370-4. PubMed ID: 17913717
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of community-onset urinary tract infections caused by plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae.
Lee CH; Lee YT; Kung CH; Ku WW; Kuo SC; Chen TL; Fung CP
J Microbiol Immunol Infect; 2015 Jun; 48(3):269-75. PubMed ID: 24239065
[TBL] [Abstract][Full Text] [Related]
10. Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand.
Moor CT; Roberts SA; Simmons G; Briggs S; Morris AJ; Smith J; Heffernan H
J Hosp Infect; 2008 Apr; 68(4):355-62. PubMed ID: 18353497
[TBL] [Abstract][Full Text] [Related]
11. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
Tamayo J; Orden B; Cacho J; Cuadros J; Gomez-Garces JL; Alos JI
Rev Esp Quimioter; 2007 Sep; 20(3):334-8. PubMed ID: 18080031
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe.
Cantón R; Novais A; Valverde A; Machado E; Peixe L; Baquero F; Coque TM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():144-53. PubMed ID: 18154538
[TBL] [Abstract][Full Text] [Related]
13. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
Ben-Ami R; Rodríguez-Baño J; Arslan H; Pitout JD; Quentin C; Calbo ES; Azap OK; Arpin C; Pascual A; Livermore DM; Garau J; Carmeli Y
Clin Infect Dis; 2009 Sep; 49(5):682-90. PubMed ID: 19622043
[TBL] [Abstract][Full Text] [Related]
14. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae.
Soge OO; Queenan AM; Ojo KK; Adeniyi BA; Roberts MC
J Antimicrob Chemother; 2006 Jan; 57(1):24-30. PubMed ID: 16319181
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology of multiresistant Escherichia coli isolates from community-onset urinary tract infections in Cornwall, England.
Woodford N; Kaufmann ME; Karisik E; Hartley JW
J Antimicrob Chemother; 2007 Jan; 59(1):106-9. PubMed ID: 17090553
[TBL] [Abstract][Full Text] [Related]
16. [Qnr-type quinolone resistance in extended-spectrum beta-lactamase producing enterobacteria in Abidjan, Ivory Coast].
Guessennd N; Bremont S; Gbonon V; Kacou-Ndouba A; Ekaza E; Lambert T; Dosso M; Courvalin P
Pathol Biol (Paris); 2008; 56(7-8):439-46. PubMed ID: 18926644
[TBL] [Abstract][Full Text] [Related]
17. Extended-spectrum β-lactamases and plasmid-mediated quinolone resistance in enterobacterial clinical isolates in the paediatric hospital of Uruguay.
García-Fulgueiras V; Bado I; Mota MI; Robino L; Cordeiro NF; Varela A; Algorta G; Gutkind G; Ayala JA; Vignoli R
J Antimicrob Chemother; 2011 Aug; 66(8):1725-9. PubMed ID: 21685201
[TBL] [Abstract][Full Text] [Related]
18. Countrywide spread of community- and hospital-acquired extended-spectrum beta-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon.
Moubareck C; Daoud Z; Hakimé NI; Hamzé M; Mangeney N; Matta H; Mokhbat JE; Rohban R; Sarkis DK; Doucet-Populaire F
J Clin Microbiol; 2005 Jul; 43(7):3309-13. PubMed ID: 16000453
[TBL] [Abstract][Full Text] [Related]
19. Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective.
Rodríguez-Baño J; Navarro MD
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():104-10. PubMed ID: 18154533
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of extended-spectrum beta-lactamases.
Rodríguez-Baño J; Pascual A
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):671-83. PubMed ID: 18847405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]